Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 491: What is the dose of Dopamine used for renal vasodilatation?

A. 2.5 ug/kg/min
B. 5-10 ug/kg/min
C. 10-20 ug/kg/min
D. 1-2 ug/kg/min (Correct Answer)

Explanation: ### Explanation Dopamine is a unique catecholamine because its pharmacological effects are **dose-dependent**, targeting different receptors as the infusion rate increases. **1. Why Option D is Correct (1-2 µg/kg/min):** At low doses (typically **<2 µg/kg/min**), dopamine selectively acts on **D1 receptors** located in the renal, mesenteric, and coronary vascular beds. Activation of these receptors causes vasodilation, increasing renal blood flow and glomerular filtration rate (GFR). This is often referred to as the "renal dose," though its clinical utility in preventing acute kidney injury is now debated. **2. Analysis of Incorrect Options:** * **Option B (5-10 µg/kg/min):** At these intermediate doses, dopamine primarily stimulates **β1-adrenergic receptors** in the heart. This results in positive inotropic effects (increased contractility) and increased cardiac output. * **Option C (10-20 µg/kg/min):** At high doses, dopamine acts predominantly on **α1-adrenergic receptors**, leading to widespread vasoconstriction and increased peripheral vascular resistance. This is used to raise blood pressure in shock but may compromise renal perfusion. * **Option A (2.5 µg/kg/min):** While close to the threshold, standard textbooks and NEET-PG patterns traditionally define the "low/renal dose" range as **1-2 µg/kg/min**. **3. High-Yield Clinical Pearls for NEET-PG:** * **Receptor Sequence:** Remember the mnemonic **DBA** (Dopaminergic → Beta → Alpha) as the dose increases. * **Fenoldopam:** A selective D1 agonist used for hypertensive emergencies; it also maintains renal perfusion. * **Clinical Note:** Current ACLS guidelines emphasize that "renal dose" dopamine does not improve survival in renal failure; its primary use remains the management of symptomatic bradycardia or cardiogenic shock.

Question 492: Which drug inhibits the rate-limiting step of acetylcholine synthesis?

A. Vesamicol
B. Hemicholinium (Correct Answer)
C. Botulinum toxin
D. Cocaine

Explanation: **Explanation:** The synthesis of Acetylcholine (ACh) occurs in the cholinergic nerve terminal [1], [5]. The **rate-limiting step** in this process is the **uptake of Choline** from the extracellular space into the neuron via a high-affinity sodium-dependent choline transporter (CHT1) [2], [4], [5]. * **Hemicholinium (Correct Answer):** This drug competitively inhibits the CHT1 transporter, blocking the entry of choline into the nerve terminal [3], [5]. Since choline availability is the bottleneck for synthesis, Hemicholinium effectively halts the production of new ACh [4]. **Analysis of Incorrect Options:** * **Vesamicol:** This drug inhibits the **VAT (Vesicle-Associated Transporter)** [5]. It prevents the storage of synthesized ACh into synaptic vesicles [3], but it does not affect the synthesis itself. * **Botulinum toxin:** This toxin acts on the presynaptic membrane to degrade **SNARE proteins** (like SNAP-25). This prevents the fusion of vesicles with the membrane, thereby inhibiting the **release** of ACh, not its synthesis [5]. * **Cocaine:** This drug primarily acts on the adrenergic system. It inhibits the **reuptake (Uptake-1)** of Norepinephrine (NE) from the synaptic cleft, prolonging its action. It has no direct role in ACh synthesis. **NEET-PG High-Yield Pearls:** * **Rate-limiting step of Catecholamine synthesis:** Tyrosine hydroxylase (inhibited by Metyrosine). * **Rate-limiting step of ACh synthesis:** Choline uptake (inhibited by Hemicholinium) [2]. * **Black Widow Spider Venom (Latrotoxin):** Causes massive, explosive release of ACh, leading to depletion. * **ACh Breakdown:** Unlike NE (which is mostly recycled via reuptake), ACh action is terminated primarily by enzymatic degradation via **Acetylcholinesterase (AChE)** in the synaptic cleft [2].

Question 493: Pralidoxime acts by?

A. Reactivating cholinesterase enzyme (Correct Answer)
B. Promoting synthesis of cholinesterase
C. Promoting synthesis of acetylcholine
D. Direct action on cholinergic receptors

Explanation: ### Explanation **Correct Option: A. Reactivating cholinesterase enzyme** Pralidoxime (2-PAM) is a **cholinesterase reactivator** used in the treatment of organophosphate (OP) poisoning. Organophosphates inhibit the enzyme Acetylcholinesterase (AChE) by phosphorylating its esteratic site, leading to a toxic accumulation of acetylcholine. Pralidoxime has a high affinity for the phosphorus atom; it binds to the anionic site of the enzyme, nucleophilically attacks the phosphate group, and pulls it away. This releases the free, functional enzyme, allowing it to resume the breakdown of acetylcholine. **Why the other options are incorrect:** * **B & C:** Pralidoxime does not influence the genetic expression or cellular machinery required for the **synthesis** of enzymes or neurotransmitters. Its action is purely biochemical and focused on the existing inhibited enzyme. * **D:** Pralidoxime does not have significant agonist or antagonist activity at nicotinic or muscarinic receptors. Its clinical benefit is indirect, mediated through the restoration of endogenous enzyme activity. **High-Yield Clinical Pearls for NEET-PG:** * **The "Aging" Phenomenon:** Pralidoxime must be administered early. Once the enzyme-toxin bond undergoes "aging" (dealkylation), the bond becomes permanent, and oximes can no longer reactivate the enzyme. * **Blood-Brain Barrier:** Pralidoxime is a quaternary ammonium compound and **does not cross the BBB**. Therefore, it is ineffective against the central nervous system effects of OP poisoning (Atropine is required for CNS symptoms). * **Specific Utility:** It is highly effective at the **Neuromuscular Junction (NMJ)**, helping reverse skeletal muscle paralysis and fasciculations, which Atropine cannot do. * **Contraindication:** Oximes are generally avoided in **Carbamate poisoning**, as the enzyme-carbamate bond is reversible and oximes may paradoxically worsen the inhibition.

Question 494: Which drug is used as a truth serum?

A. Glycopyrrolate
B. Solifenacin
C. Hyoscine (Correct Answer)
D. Acetylcholine

Explanation: **Explanation:** The correct answer is **Hyoscine (Scopolamine)**. **Why Hyoscine is the "Truth Serum":** Hyoscine is a tertiary amine belladonna alkaloid with significant central nervous system (CNS) penetration. Unlike atropine, which is stimulant in nature, hyoscine at therapeutic doses produces **sedation, amnesia, and hypnosis**. By depressing the cerebral cortex, it lowers inhibitions and impairs the subject's ability to formulate complex lies, making them more likely to provide truthful information under questioning. This pharmacological effect led to its historical (though controversial) use as a "truth serum." **Analysis of Incorrect Options:** * **A. Glycopyrrolate:** This is a **quaternary ammonium compound**. Due to its ionized state, it does not cross the blood-brain barrier and lacks CNS effects. It is primarily used to reduce secretions and reverse neuromuscular blockade. * **B. Solifenacin:** This is a competitive M3-receptor antagonist used specifically for **overactive bladder**. While it is a tertiary amine, it is highly selective for the bladder and does not produce the profound sedative-hypnotic effects required for a "truth serum." * **C. Acetylcholine:** This is the endogenous neurotransmitter for the parasympathetic system. It is rapidly degraded by acetylcholinesterase and has no clinical utility as a systemic drug or sedative. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for Motion Sickness:** Hyoscine (administered as a transdermal patch behind the pinna). * **Amnestic Effect:** Hyoscine is used in pre-anesthetic medication to produce "twilight sleep" and anterograde amnesia. * **Mydriatic Choice:** Hyoscine is a more potent mydriatic than atropine but has a shorter duration of action (3–7 days vs. 7–10 days for atropine). * **Other "Truth Serums":** Apart from Hyoscine, ultra-short-acting barbiturates like **Sodium Thiopental** and **Amobarbital** are also historically referred to as truth serums.

Question 495: Dihydroergotamine differs from ergotamine in which of the following respects?

A. It is a more potent oxytocic.
B. It has antiemetic properties.
C. It has high oral bioavailability.
D. It is a more potent alpha-adrenergic blocker and less potent vasoconstrictor. (Correct Answer)

Explanation: ### Explanation **Core Concept:** Ergot alkaloids are derived from the fungus *Claviceps purpurea*. Dihydroergotamine (DHE) is a semi-synthetic derivative produced by the hydrogenation of ergotamine. This chemical modification significantly alters its pharmacological profile, shifting its affinity toward alpha-adrenergic receptors while reducing its direct stimulatory effect on vascular smooth muscle. **Why Option D is Correct:** Dihydroergotamine (DHE) is a **more potent alpha-adrenergic blocker** but a **less potent vasoconstrictor** compared to ergotamine. While ergotamine causes significant peripheral vasoconstriction (which can lead to ergotism/gangrene), DHE has a milder effect on blood vessels, making it safer in terms of cardiovascular side effects. **Analysis of Incorrect Options:** * **Option A:** Ergotamine and ergometrine are potent oxytocics. DHE has **minimal oxytocic activity**, making it unsuitable for postpartum hemorrhage but safer during non-obstetric use. * **Option B:** Both ergotamine and DHE can cause nausea and vomiting by stimulating the **Chemoreceptor Trigger Zone (CTZ)**. DHE does not possess antiemetic properties; in fact, it is often co-administered with an antiemetic. * **Option C:** Both drugs have **poor and erratic oral bioavailability** due to extensive first-pass metabolism. DHE is typically administered parenterally (IV/IM) or via nasal spray. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Ergotamine is used for acute migraine attacks, but DHE is preferred for **intractable migraine (Status Migrainosus)** via the IV route. * **Mechanism:** Their antimigraine effect is primarily due to **5-HT$_{1B/1D}$ receptor agonism**, causing constriction of dilated cranial extracerebral vessels. * **Contraindication:** Both are strictly contraindicated in **Pregnancy** (oxytocic risk) and **Peripheral Vascular Disease** (vasoconstriction risk). * **Side Effect:** Overdose of ergotamine leads to **St. Anthony’s Fire** (severe gangrene due to persistent vasoconstriction).

Question 496: What is the drug of choice in acute central anticholinergic syndrome?

A. Neostigmine
B. Physostigmine (Correct Answer)
C. Tacrine
D. 4-amino pyridine

Explanation: **Explanation:** **Central Anticholinergic Syndrome (CAS)** is caused by an overdose of drugs that cross the blood-brain barrier (BBB) and block muscarinic receptors (e.g., Atropine, Scopolamine, or Tricyclic Antidepressants). It presents with symptoms like delirium, hallucinations, and hyperthermia. **Why Physostigmine is the Drug of Choice:** Physostigmine is a **tertiary amine** acetylcholinesterase inhibitor. Unlike most other carbamates, its lipid solubility allows it to **cross the blood-brain barrier**. By inhibiting the breakdown of acetylcholine in the synaptic cleft, it increases the concentration of neurotransmitters both peripherally and centrally, effectively reversing the CNS toxicity of anticholinergic drugs. **Analysis of Incorrect Options:** * **A. Neostigmine:** This is a **quaternary ammonium** compound. It is polar and cannot cross the BBB; therefore, it can only reverse peripheral symptoms (like tachycardia) but is ineffective for central symptoms. * **C. Tacrine:** While it is a centrally acting anticholinesterase used in Alzheimer’s disease, it is not used for acute toxicity due to its significant hepatotoxicity and shorter duration of action compared to Physostigmine. * **D. 4-amino pyridine:** This is a potassium channel blocker used to improve walking in multiple sclerosis. It increases acetylcholine release but is not a standard treatment for CAS. **High-Yield Clinical Pearls for NEET-PG:** * **Physostigmine Antidote:** It is the specific antidote for **Belladonna/Atropine poisoning**. * **Contraindication:** Avoid Physostigmine in **TCA (Tricyclic Antidepressant) overdose** if there are QRS complexes widening on ECG, as it can worsen cardiac conduction delays and trigger seizures. * **Mnemonic:** Physostigmine **"P"**enetrates the CNS; Neostigmine **"N"**o (does not).

Question 497: Why is pyridostigmine preferred in the management of myasthenia gravis?

A. It does not cross the blood-brain barrier.
B. It has a longer duration of action than neostigmine. (Correct Answer)
C. It crosses the blood-brain barrier.
D. It has a shorter duration of action than neostigmine.

Explanation: **Explanation:** **1. Why Option B is Correct:** Pyridostigmine is the drug of choice for the long-term oral maintenance of Myasthenia Gravis (MG). The primary reason is its **pharmacokinetics**: it has a longer duration of action (3–6 hours) compared to neostigmine (2–4 hours). This allows for less frequent dosing, which is crucial for maintaining stable muscle strength throughout the day and improving patient compliance. Additionally, pyridostigmine has a more gradual onset and offset, leading to fewer "fluctuations" in muscle power. **2. Why Other Options are Incorrect:** * **Option A:** While it is true that pyridostigmine (a quaternary ammonium compound) does not cross the blood-brain barrier (BBB), this is **not** the reason it is preferred *over* neostigmine. Neostigmine is also a quaternary ammonium compound and also does not cross the BBB. * **Option C:** Incorrect. Both pyridostigmine and neostigmine are polar molecules and do not cross the BBB. If they did, they would cause unwanted central cholinergic side effects. * **Option D:** Incorrect. Pyridostigmine has a longer, not shorter, duration of action than neostigmine. **3. High-Yield NEET-PG Pearls:** * **Edrophonium (Tensilon Test):** Used for diagnosis of MG due to its very short duration (5–10 mins). * **Neostigmine:** Preferred for reversing neuromuscular blockade (post-surgery) and paralytic ileus due to its faster onset. * **Physostigmine:** The only clinically used anticholinesterase that **crosses the BBB** (tertiary amine); used as an antidote for Atropine poisoning. * **Cholinergic Crisis vs. Myasthenic Crisis:** If a patient's weakness worsens after an Edrophonium test, it is a Cholinergic Crisis (overdose); if it improves, it is a Myasthenic Crisis (underdose).

Question 498: Which of the following sympathetic receptors mediates both vasoconstriction and vasodilation?

A. Alpha 1 and Alpha 2
B. Alpha 1 and Beta 1
C. Alpha 1 and Beta 2 (Correct Answer)
D. Beta 1 and Beta 2

Explanation: **Explanation** The regulation of vascular tone by the sympathetic nervous system is a classic NEET-PG topic, primarily governed by the distribution and density of adrenergic receptors in blood vessels. **Why C is correct:** * **Alpha-1 ($\alpha_1$) Receptors:** These are the predominant receptors on vascular smooth muscle. Their activation leads to the $G_q$-protein pathway, increasing intracellular calcium and causing **vasoconstriction**. This increases peripheral vascular resistance and blood pressure. * **Beta-2 ($\beta_2$) Receptors:** These are found primarily in the vasculature of skeletal muscles and coronary arteries. Their activation stimulates the $G_s$-protein pathway, increasing cAMP, which leads to smooth muscle relaxation and **vasodilation**. * **The Concept:** Epinephrine (Adrenaline) acts on both; at low doses, $\beta_2$ effects (vasodilation) predominate, while at high doses, $\alpha_1$ effects (vasoconstriction) take over. **Why other options are incorrect:** * **Option A:** Both $\alpha_1$ and $\alpha_2$ (post-junctional) mediate vasoconstriction. $\alpha_2$ does not cause vasodilation in peripheral vessels. * **Option B & D:** **Beta-1 ($\beta_1$)** receptors are primarily located in the **heart** (increasing heart rate and contractility) and the juxtaglomerular apparatus (renin release). They have a negligible direct effect on vascular diameter. **High-Yield Clinical Pearls for NEET-PG:** * **Vasomotor Reversal of Dale:** If an $\alpha$-blocker (e.g., Phentolamine) is given before Adrenaline, the vasoconstrictive $\alpha_1$ effect is blocked, leaving the $\beta_2$ effect unopposed. This results in a paradoxical fall in blood pressure (vasodilation). * **Skeletal Muscle Blood Flow:** During the "fight or flight" response, $\beta_2$ mediated vasodilation ensures increased blood flow to skeletal muscles, while $\alpha_1$ mediates constriction in the skin and viscera. * **Dopamine:** At low doses, it causes vasodilation (via $D_1$ receptors in renal/mesenteric beds); at high doses, it causes vasoconstriction (via $\alpha_1$).

Question 499: Which tissues are most sensitive to atropine?

A. The salivary, bronchial, and sweat glands (Correct Answer)
B. The gastric parietal cells
C. Smooth muscle and autonomic effectors
D. The heart

Explanation: ### Explanation Atropine is a competitive antagonist of muscarinic acetylcholine receptors. The sensitivity of different tissues to atropine follows a predictable, dose-dependent hierarchy. **1. Why Option A is Correct:** The **salivary, bronchial, and sweat glands** are the most sensitive tissues to atropine. Even at very low doses (0.5 mg), atropine effectively blocks muscarinic receptors (M3) at these sites. This results in the earliest clinical signs of atropinization: dry mouth (xerostomia), suppression of sweat (anhidrosis), and reduced bronchial secretions. **2. Why Other Options are Incorrect:** * **Option B (Gastric parietal cells):** These are the **least sensitive** to atropine. Reducing gastric acid secretion requires very high doses of atropine, which would simultaneously cause intolerable side effects (tachycardia, urinary retention, blurred vision). * **Option D (The heart):** The heart is moderately sensitive. While low doses may cause paradoxical bradycardia (due to presynaptic M1 blockade), standard doses (1 mg) cause tachycardia. However, it requires a higher dose than that needed to dry secretions. * **Option C (Smooth muscle):** Smooth muscles of the bladder and GI tract are less sensitive than exocrine glands. Larger doses are required to produce an antispasmodic effect compared to the dose needed to inhibit salivation. **3. High-Yield NEET-PG Pearls:** * **Order of Sensitivity (High to Low):** Salivary/Sweat/Bronchial glands > Eye/Heart > Smooth muscles (GI/Bladder) > Gastric glands. * **The "Atropine Paradox":** At very low doses, atropine can cause **bradycardia** by blocking inhibitory presynaptic M1 receptors on vagal nerve endings. * **Clinical Sign:** The "earliest" sign of atropine action is **dryness of the mouth**, while the "last" function to be affected is **gastric secretion**. * **Mnemonic for Atropine Toxicity:** "Hot as a hare, red as a beet, dry as a bone, blind as a bat, and mad as a hatter."

Question 500: D-Tubocurarine acts by?

A. Inhibiting nicotinic receptors at the myoneural junction (Correct Answer)
B. Inhibiting nicotinic receptors at the autonomic ganglion
C. Producing a depolarizing block
D. Inhibiting the re-uptake of acetylcholine

Explanation: **Explanation:** **1. Why Option A is Correct:** D-Tubocurarine (d-TC) is the prototype **competitive (non-depolarizing) neuromuscular blocker**. It acts by reversibly binding to the **Nicotinic-M ($N_M$) receptors** located at the motor endplate of the myoneural (neuromuscular) junction. By competing with Acetylcholine (ACh) for these sites, it prevents endplate depolarization, leading to flaccid skeletal muscle paralysis. **2. Why the Other Options are Incorrect:** * **Option B:** While d-TC can block Nicotinic-G ($N_G$) receptors at autonomic ganglia in high doses (leading to hypotension), its primary therapeutic action and classification are based on its effect at the **myoneural junction**. * **Option C:** D-Tubocurarine produces a **non-depolarizing block**. Depolarizing blocks are characteristic of drugs like **Succinylcholine**, which act as agonists that cause persistent depolarization. * **Option D:** Inhibition of ACh re-uptake is not a mechanism of muscle relaxants. Hemicholinium is a drug that inhibits choline uptake, but d-TC acts post-synaptically. **3. High-Yield Clinical Pearls for NEET-PG:** * **Histamine Release:** d-TC is notorious for causing histamine release, which can lead to bronchospasm, hypotension, and urticaria. * **Reversibility:** The block produced by d-TC can be reversed by **Acetylcholinesterase inhibitors** (e.g., Neostigmine), which increase the concentration of ACh to outcompete the drug. * **Order of Paralysis:** Small, rapidly moving muscles (eyes, fingers) are paralyzed first; the **diaphragm** is the last to be affected and the first to recover. * **Hofmann Elimination:** Remember that **Atracurium and Cisatracurium** are preferred in organ failure as they undergo spontaneous degradation (Hofmann elimination), unlike d-TC.

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free